Nasal Vaccines Market
According to Intent Market Research, the Nasal Vaccines Market is expected to grow from USD 1.4 Billion in 2024-e at a CAGR of 11.0% to touch USD 2.6 Billion by 2030. The Nasal Vaccines Market is dominated by key players such as Sanofi, Pfizer Inc., AstraZeneca, GlaxoSmithKline, Johnson & Johnson, and Novavax.